TDC
CDNA icon

Thompson Davis & Co’s CareDx CDNA Stock Holding History

Thompson Davis & Co’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
+7,300
New +$159K 0.12% 138
2025
Q3 		– Sell
-16,900
Closed -$330K – 156
2025
Q2 		$330K Sell
16,900
-5,100
-23% -$90.6K 0.23% 74
2025
Q1 		$391K Buy
22,000
+5,950
+37% +$128K 0.31% 62
2024
Q4 		$344K Buy
16,050
+950
+6% +$23.1K 0.22% 71
2024
Q3 		$471K Sell
15,100
-2,725
-15% -$67.8K 0.35% 50
2024
Q2 		$277K Buy
+17,825
New +$215K 0.24% 76
2018
Q3 		$433K Sell
15,000
-29,193
-66% -$546K 0.94% 19
2018
Q2 		$541K Sell
44,193
-29,023
-40% -$333K 1.29% 11
2018
Q1 		$584K Sell
73,216
-135,709
-65% -$836K 1.54% 10
2017
Q4 		$1.53M Buy
208,925
+5,233
+3% +$32.6K 3.63% 1
2017
Q3 		$754K Buy
203,692
+197,692
+3,295% +$415K 1.33% 9
2017
Q2 		$7K Buy
6,000
+1,500
+33% +$1.59K 0.01% 742
2017
Q1 		$6K Buy
4,500
+2,500
+125% +$5.57K 0.01% 839
2016
Q4 		$5K Hold
2,000
– – 0.01% 847
2016
Q3 		$7K Hold
2,000
– – 0.01% 739
2016
Q2 		$9K Hold
2,000
– – 0.01% 656
2016
Q1 		$10K Hold
2,000
– – 0.01% 646
2015
Q4 		$13K Hold
2,000
– – 0.02% 586
2015
Q3 		$8K Hold
2,000
– – 0.01% 710
2015
Q2 		$13K Sell
2,000
-1,500
-43% -$8.15K 0.02% 657
2015
Q1 		$19K Buy
+3,500
New +$23.1K 0.02% 534

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Thompson Davis & Co's CDNA Position: Q2 2026 in Review

Thompson Davis & Co opened a new position in CareDx (CDNA) in Q2 2026: 7,300 shares worth $208K. The stake represents 0.12% of the portfolio and ranks #138 among its holdings. This is a return to the name: Thompson Davis & Co previously reported a position in CDNA as recently as Q2 2025.

Thompson Davis & Co first reported a position in CDNA in Q1 2015 and has held it in 21 quarters since. The position peaked at $1.53M in Q4 2017. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Thompson Davis & Co held 7,300 shares of CareDx worth $208K as of Q2 2026.
  • CareDx was a new Thompson Davis & Co position in Q2 2026.
  • CareDx made up 0.12% of Thompson Davis & Co's portfolio in Q2 2026, its #138 holding.
  • Thompson Davis & Co first reported a position in CareDx in Q1 2015 and has held it in 21 quarters since.
  • Thompson Davis & Co's CareDx position peaked at $1.53M in Q4 2017.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Thompson Davis & Co's 13F filing for Q2 2026, filed 29 Jul 2026.